---
figid: PMC7873566__fimmu-11-621931-g003
figtitle: Formation of the signaling-competent IL-1R complex and downstream IL-1 signaling
organisms:
- Influenza A virus
- Dengue virus
- Orthomyxoviridae
- Vaccinia virus
- West Nile virus
- H5N1 subtype
- Variola virus
- Modified Vaccinia Ankara virus
- Staphylococcus aureus
- Mycobacterium tuberculosis
- Salmonella enterica subsp. enterica serovar Typhimurium
- Listeria monocytogenes
- Bacteroides fragilis
- Mycolicibacterium smegmatis
- Pasteurella multocida
- Plasmodium falciparum
- Toxoplasma gondii
- Leishmania major
- Leishmania amazonensis
- Heligmosomoides bakeri
- Arachis hypogaea
- Cryptococcus neoformans
- Blastomyces dermatitidis
- Mus musculus
- Rattus norvegicus
- Homo sapiens
- NA
organisms_ner:
- Homo sapiens
- Rattus norvegicus
- Mus musculus
- Danio rerio
pmcid: PMC7873566
filename: fimmu-11-621931-g003.jpg
figlink: pmc/articles/PMC7873566/figure/f3/
number: F3
caption: 'Formation of the signaling-competent IL-1R complex and downstream IL-1 signaling.
  (1) Extracellular IL-1β makes two contacts with IL-1R1 and induces a conformational
  change in the primary receptor. (2) This allows IL-1R1 to recruit and bind to co-receptor
  IL-1R3. (3) Receptor dimerization leads to scaffolding of intracellular receptor
  TIR domains via the R-interface. (4) and (5) Formation of an intracellular TIR scaffold
  allows for recruitment of the MyD88 adaptor molecule via S-interface interactions.
  MyD88 comprises an N-terminal death domain (DD), an intermediate domain (ID) and
  a C-terminal TIR domain. IRAK-1, IRAK-4 and/or IRAK-2 are recruited. These molecules
  comprise an N-terminal DD and a C-terminal catalytic domain. Under steady-state,
  IRAK-1 is bound to Tollip. As such, the Myddosome is formed. (6) IRAK-4 auto-phosphorylates
  and gains full activity, in turn activating IRAK-1 by phosphorylation. This induces
  rapid IRAK-1 auto-phosphorylation. (7) A conformational change in IRAK-1 allows
  its dissociation from Tollip. Different IRAK-1 oligomers form a scaffold for TRAF6,
  which becomes activated upon oligomerization. UBC13 and UEV1A facilitate TRAF6 self-poly-ubiquitination
  (K63-linked). TAB2 and TAB3 recruit TAB1 and the MAP3K TAK1 to the K63-linked poly-ubiquitin
  chain on TRAF6. (8) TRAF6 poly-ubiquitinates TAK1. (9) Initiation of the canonical
  NF-κB pathway: NEMO binds to the poly-ubiquitin chain on TAK1 and recruits IKKα
  and IKKβ. IKKα and IKKβ become activated following phosphorylation by TAK1. (10)
  and (11) IKKα and IKKβ phosphorylate IκBα, which allows for its dissociation from
  p50/p65 NF-κB. (12) Free p50/p65 NF-κB translocates to the nucleus and binds to
  specific κB sites on DNA, as such inducing gene expression. (13) Initiation of the
  MAPK pathway: the MAP3K MAP3K3 binds the poly-ubiquitin chain on TAK1. MAP3K3 becomes
  activated following phosphorylation by TRAF6. IKKα and IKKβ activate TPL2 by phosphorylation.
  MAP3K3, TAK1 and TPL2 activate different MAP2Ks by phosphorylation. (14) MAP2Ks
  activate the p38, JNK and ERK MAPKs by phosphorylation. (15) In turn, MAPKs activate
  different transcription factors by phosphorylation, as such inducing gene expression.
  (16) Binding of IL-1β to sIL-1R2 does not induce signal transduction. (17) Binding
  of IL-1β to the signaling-incompetent IL-1R complex does not induce signal transduction.
  (18) Binding of IL-1Ra to the signaling-competent IL-1R complex does not induce
  signal transduction. Created with BioRender.com.'
papertitle: Interleukin-1 as Innate Mediator of T Cell Immunity.
reftext: Bram Van Den Eeckhout, et al. Front Immunol. 2020;11:621931.
year: '2020'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9446961
figid_alias: PMC7873566__F3
figtype: Figure
redirect_from: /figures/PMC7873566__F3
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7873566__fimmu-11-621931-g003.html
  '@type': Dataset
  description: 'Formation of the signaling-competent IL-1R complex and downstream
    IL-1 signaling. (1) Extracellular IL-1β makes two contacts with IL-1R1 and induces
    a conformational change in the primary receptor. (2) This allows IL-1R1 to recruit
    and bind to co-receptor IL-1R3. (3) Receptor dimerization leads to scaffolding
    of intracellular receptor TIR domains via the R-interface. (4) and (5) Formation
    of an intracellular TIR scaffold allows for recruitment of the MyD88 adaptor molecule
    via S-interface interactions. MyD88 comprises an N-terminal death domain (DD),
    an intermediate domain (ID) and a C-terminal TIR domain. IRAK-1, IRAK-4 and/or
    IRAK-2 are recruited. These molecules comprise an N-terminal DD and a C-terminal
    catalytic domain. Under steady-state, IRAK-1 is bound to Tollip. As such, the
    Myddosome is formed. (6) IRAK-4 auto-phosphorylates and gains full activity, in
    turn activating IRAK-1 by phosphorylation. This induces rapid IRAK-1 auto-phosphorylation.
    (7) A conformational change in IRAK-1 allows its dissociation from Tollip. Different
    IRAK-1 oligomers form a scaffold for TRAF6, which becomes activated upon oligomerization.
    UBC13 and UEV1A facilitate TRAF6 self-poly-ubiquitination (K63-linked). TAB2 and
    TAB3 recruit TAB1 and the MAP3K TAK1 to the K63-linked poly-ubiquitin chain on
    TRAF6. (8) TRAF6 poly-ubiquitinates TAK1. (9) Initiation of the canonical NF-κB
    pathway: NEMO binds to the poly-ubiquitin chain on TAK1 and recruits IKKα and
    IKKβ. IKKα and IKKβ become activated following phosphorylation by TAK1. (10) and
    (11) IKKα and IKKβ phosphorylate IκBα, which allows for its dissociation from
    p50/p65 NF-κB. (12) Free p50/p65 NF-κB translocates to the nucleus and binds to
    specific κB sites on DNA, as such inducing gene expression. (13) Initiation of
    the MAPK pathway: the MAP3K MAP3K3 binds the poly-ubiquitin chain on TAK1. MAP3K3
    becomes activated following phosphorylation by TRAF6. IKKα and IKKβ activate TPL2
    by phosphorylation. MAP3K3, TAK1 and TPL2 activate different MAP2Ks by phosphorylation.
    (14) MAP2Ks activate the p38, JNK and ERK MAPKs by phosphorylation. (15) In turn,
    MAPKs activate different transcription factors by phosphorylation, as such inducing
    gene expression. (16) Binding of IL-1β to sIL-1R2 does not induce signal transduction.
    (17) Binding of IL-1β to the signaling-incompetent IL-1R complex does not induce
    signal transduction. (18) Binding of IL-1Ra to the signaling-competent IL-1R complex
    does not induce signal transduction. Created with BioRender.com.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - IL1R1
  - IL1RAP
  - IL1R2
  - IL18
  - RPL18
  - IGKV1D-13
  - IGKV1-13
  - TOLLIP
  - TRAF6
  - TAB1
  - IRAK1
  - TAB3
  - TAB2
  - MAP3K7
  - NR2C2
  - IRAK4
  - UBC
  - RPS27A
  - UBE2V1
  - IKBKG
  - NFKBIA
  - IRAK2
  - TNF
  - NFKB1
  - CXCL8
  - PTGS2
  - MAPK1
  - MAPK3
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK14
  - MAPK8
  - MAPK9
  - MAPK10
  - CRK
  - AIMP2
  - GRAP2
  - AHSA1
  - POLDIP2
  - MAP2K3
  - MAP2K4
  - MAP3K8
  - MAP2K6
  - MAP2K7
  - MAP2K1
  - IKBKB
  - Il1r1
  - Il1r2
  - Il18
  - Tollip
  - Traf6
  - Tab1
  - Irak1
  - Tab3
  - Tab2
  - Map3k7
  - Irak4
  - Ubc
  - Ikbkg
  - Irak2
  - Nfkbia
  - Tnf
  - Nfkb1
  - Ptgs2
  - Mapk14
  - Map2k3
  - Map2k4
  - Map3k8
  - Map2k6
  - Map2k7
  - Rpl18
  - Nr2c2
  - Uba52
  - Ubb
  - Rps27a
  - Ap3b1
  - Crk
  - Grap2
  - Syp
  - Ahsa1
  - Ikbkb
  - il1rl1
  - tollip
  - traf6
  - tab1
  - irak1
  - tab3
  - tab2
  - irak4
  - ubc
  - si:ch211-202a12.4
  - ubb
  - ikbkg
  - nfkbiab
  - tnfrsfa
  - tnfb
  - cxcl8a
  - ptgs2a
  - mapk14a
  - map2k6
  - map2k4a
  - map2k7
  - 'NO'
  - 1Ra O
---
